About: Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug–induced clinical remission: Evidence from an imaging study may explain structural progression

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug–induced clinical remission: Evidence from an imaging study may explain structural progression Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

article

Attributes	Values
rdf:type	Item
description	article (en) ലേഖനം (ml) wetenschappelijk artikel (nl) наукова стаття, опублікована у 2006 (uk) article scientifique publié en 2006 (fr) im Jahr 2006 veröffentlichter wissenschaftlicher Artikel (de)
publication date	wds:Q56420367-0EA5287C-E8CE-4A80-8E80-29CD4C8A3D98
publication date	2006-01-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q56420367-4D295041-853A-47F9-9D4C-5CE08599E532 wds:Q56420367-4E22B398-09F1-4187-ACD3-890EFACB087D wds:Q56420367-94840B71-6248-42DF-AFA6-808B9FA5A82C wds:Q56420367-CAE341A9-20DD-4695-A1C4-48DFF2AE120C wds:Q56420367-FB67E1E3-B744-4DC7-9314-5FAA219DB4BC
author name string	A. K. Brown P. J. O'Connor M. A. Quinn C. G. Peterfy Z. Karim
rdfs:label	Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug–induced clinical remission: Evidence from an imaging study may explain structural progression (en) Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug–induced clinical remission: Evidence from an imaging study may explain structural progression (nl) Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug–induced clinical remission: Evidence from an imaging study may explain structural progression (en-gb)
skos:prefLabel	Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug–induced clinical remission: Evidence from an imaging study may explain structural progression (en) Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug–induced clinical remission: Evidence from an imaging study may explain structural progression (nl) Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug–induced clinical remission: Evidence from an imaging study may explain structural progression (en-gb)
name	Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug–induced clinical remission: Evidence from an imaging study may explain structural progression (en) Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug–induced clinical remission: Evidence from an imaging study may explain structural progression (nl) Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug–induced clinical remission: Evidence from an imaging study may explain structural progression (en-gb)
author	wds:Q56420367-084A4B58-5B6B-41E6-ADF8-51E6D89E305E wds:Q56420367-2FCF7611-CEE7-462A-9BEB-FE6DB4E6066A wds:Q56420367-AC030389-8DB8-4DDC-B66C-845BC586470D wds:Q56420367-CE0861E7-A689-4781-9A21-777327506B76
author	Philip G Conaghan Paul Emery Elizabeth M A Hensor Richard J. Wakefield
title	wds:Q56420367-0AB046D1-D7F6-452D-9213-A8FFDC5C5ECE
title	Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug–induced clinical remission: Evidence from an imaging study may explain structural progression (en)
page(s)	wds:Q56420367-C7C309AC-4054-47EA-BE38-9BF989AEEEBC
page(s)	3761-3773
instance of	wds:Q56420367-4F277F5B-4B88-4FFA-B51C-8BE713796D63
instance of	scholarly article
main subject	wds:Q56420367-5EAA6B4E-1C76-45DF-8A1E-41FDBFBFCCE9 wds:Q56420367-B74FDF9F-C7DD-4433-AF00-705A5140D7EB wds:Q56420367-C7F88AF6-4F0F-4393-8A75-1B3BD5CCA36D wds:Q56420367-DCCE6D05-AFC7-4F19-BB44-5160EED15BAD
main subject	rheumatoid arthritis rheumatology Patients immunology
PubMed ID	wds:Q56420367-484DEE5E-D36B-44D3-92BF-6413E6662C9E
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17133543
PubMed ID	17133543
published in	wds:Q56420367-3BBEE9EE-580D-41EC-BD0C-6CA5D40C7C73
published in	Arthritis and Rheumatism
issue	wds:Q56420367-90C844FA-C2E2-4EA5-A791-3C2616037C36
volume	wds:Q56420367-A80DDC64-7210-4EFD-A6C5-57631C41F061
issue	12
volume	54
DOI	wds:Q56420367-1757BD6B-9DCB-43AD-8496-F0DE3D830838
DOI	http://dx.doi.org/10.1002/ART.22190
DOI	10.1002/ART.22190
ResearchGate publication ID	wds:Q56420367-C32ACB74-5B16-431C-98A5-7DA8305F5F96
ResearchGate publication ID	6664253
Dimensions Publication ID	wds:Q56420367-30A133DC-820D-4AD5-A31A-E7B99829E187
Dimensions Publication ID	1021400128
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q56420367
is cites work of	Treating rheumatoid arthritis to target: recommendations of an international task force Tumor necrosis factor α induces sustained signaling and a prolonged and unremitting inflammatory response in rheumatoid arthritis synovial fibroblasts Resolution of inflammation induces osteoblast function and regulates the Wnt signaling pathway Tumor necrosis factor blocking therapy alters joint inflammation and hypoxia Subclinical synovitis detected by macrophage PET, but not MRI, is related to short-term flare of clinical disease activity in early RA patients: an exploratory study Persistence of subclinical sonographic joint activity in rheumatoid arthritis in sustained clinical remission. Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial My treatment approach to rheumatoid arthritis Ultrasound composite scores for the assessment of inflammatory and structural pathologies in Psoriatic Arthritis (PsASon-Score). Ultrasonographic evaluation of joint involvement in early rheumatoid arthritis in clinical remission: power Doppler signal predicts short-term relapse. Disparity between ultrasound and clinical findings in psoriatic arthritis. Atherosclerosis in rheumatoid arthritis: is it all about inflammation? Juvenile Idiopathic Arthritis: Diagnosis and Treatment Towards a role of ultrasound in children with juvenile idiopathic arthritis Synovial and inflammatory diseases in childhood: role of new imaging modalities in the assessment of patients with juvenile idiopathic arthritis Sonographic joint assessment in rheumatoid arthritis: associations with clinical joint assessment during a state of remission Should anti-TNF therapy be discontinued in rheumatoid arthritis patients undergoing elective orthopaedic surgery? A systematic review of the evidence Using ultrasonography to facilitate best practice in diagnosis and management of RA. Low-dose oral prednisone improves clinical and ultrasonographic remission rates in early rheumatoid arthritis: results of a 12-month open-label randomised study. American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials Changing Crohn's disease management: need for new goals and indices to prevent disability and improve quality of life The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now? Is there subclinical synovitis in early psoriatic arthritis? A clinical comparison with gray-scale and power Doppler ultrasound Can Synovial Pathobiology Integrate with Current Clinical and Imaging Prediction Models to Achieve Personalized Health Care in Rheumatoid Arthritis? Role of magnetic resonance imaging in the diagnosis and prognosis of rheumatoid arthritis Ultrasound joint inflammation in rheumatoid arthritis in clinical remission: how many and which joints should be assessed? Golimumab - a new tool in the armoury against inflammatory arthritis The neutrophil protein S100A12 is associated with a comprehensive ultrasonographic synovitis score in a longitudinal study of patients with rheumatoid arthritis treated with adalimumab The soluble biomarker calprotectin (an S100 protein) is associated to ultrasonographic synovitis scores and is sensitive to change in patients with rheumatoid arthritis treated with adalimumab American College of Rheumatology report on reasonable use of musculoskeletal ultrasonography in rheumatology clinical practice Equivalent responses to disease-modifying antirheumatic drugs initiated at any time during the first 15 months after symptom onset in patients with seropositive rheumatoid arthritis Emerging role of ultrasonography in rheumatoid arthritis: optimizing diagnosis, measuring disease activity and identifying prognostic factors Extremity magnetic resonance imaging in rheumatoid arthritis: Updated literature review

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 171 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software